HUP2100119A1 - Deuterium-depleted preparations to normalize the body's leptin concentration - Google Patents
Deuterium-depleted preparations to normalize the body's leptin concentrationInfo
- Publication number
- HUP2100119A1 HUP2100119A1 HU2100119A HUP2100119A HUP2100119A1 HU P2100119 A1 HUP2100119 A1 HU P2100119A1 HU 2100119 A HU2100119 A HU 2100119A HU P2100119 A HUP2100119 A HU P2100119A HU P2100119 A1 HUP2100119 A1 HU P2100119A1
- Authority
- HU
- Hungary
- Prior art keywords
- normalize
- deuterium
- leptin concentration
- depleted
- preparations
- Prior art date
Links
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 title 1
- 102000016267 Leptin Human genes 0.000 title 1
- 108010092277 Leptin Proteins 0.000 title 1
- 229910052805 deuterium Inorganic materials 0.000 title 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
- 229940039781 leptin Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU2100119A HUP2100119A1 (en) | 2021-03-19 | 2021-03-19 | Deuterium-depleted preparations to normalize the body's leptin concentration |
| PCT/HU2021/050022 WO2021191643A1 (en) | 2020-03-26 | 2021-03-24 | Compositions comprising deuterium depleted water for the normalization of leptin concentration in the body system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU2100119A HUP2100119A1 (en) | 2021-03-19 | 2021-03-19 | Deuterium-depleted preparations to normalize the body's leptin concentration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP2100119A1 true HUP2100119A1 (en) | 2022-08-28 |
Family
ID=89993321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU2100119A HUP2100119A1 (en) | 2020-03-26 | 2021-03-19 | Deuterium-depleted preparations to normalize the body's leptin concentration |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP2100119A1 (en) |
-
2021
- 2021-03-19 HU HU2100119A patent/HUP2100119A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2465703B (en) | Cosmetic treatment using p-coumaric acid derivatives for the reduction of skin pigmentation | |
| FI7594U1 (en) | Absorption piece for attachment to the human body | |
| AU6432000A (en) | Breathable garment to be worn to improve the comfort of the human body | |
| WO2002043652A3 (en) | Anti-proliferative drugs | |
| CY1110061T1 (en) | COMPOSITIONS INCLUDING MODAFINILIS COMPOUNDS | |
| HK1073252A1 (en) | Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body | |
| EA200601288A1 (en) | 1,3-DIPHENYLPROP-2-EN-1-SHE DERIVATIVES, METHOD OF THEIR RECEIVING AND APPLICATION | |
| EP1896005A4 (en) | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease including sage and rosemary derived compounds | |
| TW200718430A (en) | Cosmetic powder | |
| HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
| AU2003273843A8 (en) | Use of skin-protecting substances | |
| HUP2100119A1 (en) | Deuterium-depleted preparations to normalize the body's leptin concentration | |
| IL118218A0 (en) | Terpenoidic derivatives and pharmaceutical compositions containing them | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| GB0425633D0 (en) | Topical formulations for use in the treatment or prevention of dermatological conditions | |
| GB0427637D0 (en) | Topical formulations for use in the treatment or prevention of skin cancers | |
| TW200512183A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia | |
| FR2885301B1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION FOR DECREASING AND / OR CORRECTING THE REDNESS OF THE SKIN | |
| ITMI20022144A1 (en) | DEVICE TO LIMIT THE ABSORPTION OF ELECTROMAGNETIC RADIATIONS BY THE HUMAN BODY. | |
| AU2003209489A1 (en) | Medical use of captopril for the treatment and prophylaxis of cancer | |
| TW200503761A (en) | The composition of cosmetics which contain lotus | |
| IL157535A0 (en) | Preparations for the prevention of skin atrophy | |
| ITTN20050013A1 (en) | DEVELOPMENT OF PHARMACEUTICAL AND / OR COSMETIC PRODUCTS FOR HUMAN USE WITH ACTIVE MELATONIN PRINCIPLE, BASED ON THE ABILITY TO IMPLEMENT THE DHT AT THE LEVEL OF SEBACEOUS GLANDS. | |
| PL350327A1 (en) | Compositions for the treatment of skin diseases | |
| GB0318890D0 (en) | Improvements in and relating to the treatment of sunburn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |